COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

被引:130
|
作者
Chi, Wei-Yu [1 ]
Li, Yen-Der [2 ]
Huang, Hsin-Che [3 ]
Chan, Timothy En Haw [4 ,5 ,6 ]
Chow, Sih-Yao [7 ]
Su, Jun-Han [2 ]
Ferrall, Louise [8 ]
Hung, Chien-Fu [8 ,9 ,10 ]
Wu, T-C [8 ,9 ,10 ,11 ,12 ]
机构
[1] Weill Cornell Med, Physiol Biophys & Syst Biol Grad Program, New York, NY USA
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA
[4] Max Planck Inst Immunobiol & Epigenet, Int Max Planck Res Sch Immunobiol Epigenet & Meta, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, Dept Urol, Freiburg, Germany
[6] Univ Freiburg, Fac Biol, Freiburg, Germany
[7] EirGenix Inc, Downstream Proc Sci, Hsinchu, Taiwan
[8] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA
[9] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[10] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD 21218 USA
[11] Johns Hopkins Univ, Dept Microbiol & Immunol, Baltimore, MD 21218 USA
[12] Johns Hopkins Med Inst, CRB 2 Room 309,1550 Orleans St, Baltimore, MD 21231 USA
关键词
COVID-19; Vaccine; Immunity; Variant; SARS-CoV-2; NCOV-19; AZD1222; VACCINE; MESSENGER-RNA; CHADOX1; BNT162B2; SINGLE-BLIND; NEUTRALIZING ANTIBODY; OMICRON VARIANT; NON-INFERIORITY; UNITED-STATES; IMMUNOGENICITY;
D O I
10.1186/s12929-022-00853-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Coronavirus Disease 2019 (COVID-19) has been the most severe public health challenge in this century. Two years after its emergence, the rapid development and deployment of effective COVID-19 vaccines have successfully controlled this pandemic and greatly reduced the risk of severe illness and death associated with COVID-19. However, due to its ability to rapidly evolve, the SARS-CoV-2 virus may never be eradicated, and there are many important new topics to work on if we need to live with this virus for a long time. To this end, we hope to provide essential knowledge for researchers who work on the improvement of future COVID-19 vaccines. In this review, we provided an up-to-date summary for current COVID-19 vaccines, discussed the biological basis and clinical impact of SARS-CoV-2 variants and subvariants, and analyzed the effectiveness of various vaccine booster regimens against different SARS-CoV-2 strains. Additionally, we reviewed potential mechanisms of vaccine-induced severe adverse events, summarized current studies regarding immune correlates of protection, and finally, discussed the development of next-generation vaccines.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
    Wei-Yu Chi
    Yen-Der Li
    Hsin-Che Huang
    Timothy En Haw Chan
    Sih-Yao Chow
    Jun-Han Su
    Louise Ferrall
    Chien-Fu Hung
    T.-C. Wu
    Journal of Biomedical Science, 29
  • [2] Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2
    Dhawan, Manish
    Bin Emran, Talha
    Choudhary, Om Prakash
    ANNALS OF MEDICINE AND SURGERY, 2022, 77
  • [3] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515
  • [4] Correlates of Vaccine-Induced Protection against SARS-CoV-2
    Koch, Till
    Mellinghoff, Sibylle C.
    Shamsrizi, Parichehr
    Addo, Marylyn M.
    Dahlke, Christine
    VACCINES, 2021, 9 (03)
  • [5] An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
    Hillary, Varghese Edwin
    Ceasar, Stanislaus Antony
    HELIYON, 2023, 9 (03)
  • [6] COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
    Zarebska-Michaluk, Dorota
    Hu, Chenlin
    Brzdek, Michal
    Flisiak, Robert
    Rzymski, Piotr
    VACCINES, 2022, 10 (08)
  • [7] Influenza Vaccine and COVID-19 Pandemic: Could This Vaccine Help Limit the Potential Adverse Consequences of SARS-CoV-2?
    Mosaed, Reza
    Fasihi, Hossein
    Norouzi, Amir
    Anjomanian, Vahid
    Ardalan, Mohammad Afshar
    Noodeh, Farshid Alazmani
    Khoshdel, Ali Reza
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
  • [8] Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
    Zhang, Yandi
    Banga Ndzouboukou, Jo-Lewis
    Gan, Mengze
    Lin, Xiaosong
    Fan, Xionglin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [10] Vaccine against COVID-19 or against SARS-CoV-2 infection?
    Rieske, Piotr
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (03) : 131 - 145